Inhibition of stearoyl CoA desaturase‐1 activity suppresses tumour progression and improves prognosis in human bladder cancer

Urinary bladder neoplasm is one of the most common cancers worldwide. Cancer stem cells (CSCs) have been proven to be an important cause of cancer progression and poor prognosis. In the present study, we established bladder CSCs and identified the crucial differentially expressed genes (DEGs) between these cells and parental bladder cancer cells. Analyses of bioinformatics data and clinical samples from local hospitals showed that stearoyl CoA desaturase‐1 (SCD) was the key factor among the DEGs. A significant correlation between SCD gene expression and poor prognosis among patients with bladder cancer was observed in our data. Loss‐of‐function experiments further revealed that the SCD inhibitor A939572 and SCD gene interference reduced cell proliferation and invasion. The above data suggest that SCD may serve as a novel marker for the prediction of tumour progression and poor prognosis in patients with bladder cancer.

[1]  Gerardo Botti,et al.  Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells. , 2017, Cancer letters.

[2]  Yu Xia,et al.  Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells. , 2017, Cell stem cell.

[3]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[4]  A. Harris,et al.  Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environments , 2016, Cancer & metabolism.

[5]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[6]  Anneleen Daemen,et al.  Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors , 2015, Proceedings of the National Academy of Sciences.

[7]  D. Hardie,et al.  Molecular Pathways: Is AMPK a Friend or a Foe in Cancer? , 2015, Clinical Cancer Research.

[8]  J. Copland,et al.  Aberrant lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl CoA desaturase 1 as a novel therapeutic target. , 2015, The Journal of clinical endocrinology and metabolism.

[9]  N. Benvenisty,et al.  Elimination of undifferentiated cancer cells by pluripotent stem cell inhibitors. , 2014, Journal of molecular cell biology.

[10]  A. Kamat,et al.  Bladder cancer stem cells: biological and therapeutic perspectives. , 2014, Current stem cell research & therapy.

[11]  R. Mancini,et al.  Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells , 2013, Cell Death and Disease.

[12]  J. Copland,et al.  Stearoyl-CoA Desaturase 1 Is a Novel Molecular Therapeutic Target for Clear Cell Renal Cell Carcinoma , 2013, Clinical Cancer Research.

[13]  Jin Zhang,et al.  Positive feedback loop and synergistic effects between hypoxia‐inducible factor‐2α and stearoyl–CoA desaturase‐1 promote tumorigenesis in clear cell renal cell carcinoma , 2013, Cancer science.

[14]  O. Yanuka,et al.  Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen. , 2013, Cell stem cell.

[15]  E. Rassart,et al.  Decreasing stearoyl‐CoA desaturase‐1 expression inhibits β‐catenin signaling in breast cancer cells , 2013, Cancer science.

[16]  Jinfeng Liu,et al.  FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth. , 2012, Cancer research.

[17]  J. W. Chisholm,et al.  Stearoyl-CoA desaturase activity modulates the activation of epidermal growth factor receptor in human lung cancer cells , 2012, Experimental biology and medicine.

[18]  J. Fargnoli,et al.  Cancer Cell Dependence on Unsaturated Fatty Acids Implicates Stearoyl-CoA Desaturase as a Target for Cancer Therapy , 2011, Molecular Cancer Research.

[19]  Chawnshang Chang,et al.  Stearoyl CoA desaturase (SCD) facilitates proliferation of prostate cancer cells through enhancement of androgen receptor transactivation , 2011, Molecules and cells.

[20]  F. Clavel-Chapelon,et al.  The fatty acid desaturation index of blood lipids, as a biomarker of hepatic stearoyl-CoA desaturase expression, is a predictive factor of breast cancer risk , 2011, Current opinion in lipidology.

[21]  D. Sabatini,et al.  mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.

[22]  D. McConkey,et al.  Bladder cancer stem cells. , 2010, Current stem cell research & therapy.

[23]  D. Hess,et al.  Inhibition of StearoylCoA Desaturase Activity Blocks Cell Cycle Progression and Induces Programmed Cell Death in Lung Cancer Cells , 2010, PloS one.

[24]  S. Culine,et al.  Abrogation of De novo Lipogenesis by Stearoyl-CoA Desaturase 1 Inhibition Interferes with Oncogenic Signaling and Blocks Prostate Cancer Progression in Mice , 2010, Molecular Cancer Therapeutics.

[25]  M. Bonini,et al.  Inhibition of StearoylCoA Desaturase-1 Inactivates Acetyl-CoA Carboxylase and Impairs Proliferation in Cancer Cells: Role of AMPK , 2009, PloS one.

[26]  Howard Y. Chang,et al.  Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells , 2009, Proceedings of the National Academy of Sciences.

[27]  A. I. Glushkov,et al.  Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitors. , 2009, Bioorganic & medicinal chemistry letters.

[28]  M. Barbacid,et al.  Cell cycle, CDKs and cancer: a changing paradigm , 2009, Nature Reviews Cancer.

[29]  R. Isseroff,et al.  Label-retaining cells of the bladder: candidate urothelial stem cells. , 2008, American journal of physiology. Renal physiology.

[30]  P. Polakis.  The many ways of Wnt in cancer. , 2007, Current opinion in genetics & development.

[31]  Irving L Weissman,et al.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.

[32]  R. A. Igal,et al.  Stearoyl-CoA Desaturase Is Involved in the Control of Proliferation, Anchorage-independent Growth, and Survival in Human Transformed Cells* , 2005, Journal of Biological Chemistry.

[33]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[34]  P. van’t Veer,et al.  Tissue stores of individual monounsaturated fatty acids and breast cancer: the EURAMIC study. European Community Multicenter Study on Antioxidants, Myocardial Infarction, and Breast Cancer. , 1998, The American journal of clinical nutrition.

[35]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[36]  P. Ducimetiere,et al.  Fatty acid proportions in cholesterol esters and risk of premature death from cancer in middle aged French men , 1995, BMJ.

[37]  C. Couet,et al.  Prognostic significance of tumor phosphatidylcholine stearic acid level in breast carcinoma , 1991, Breast Cancer Research and Treatment.

[38]  R. Zoeller,et al.  The importance of the stearoyl-CoA desaturase system in octadecenoate metabolism in the Morris hepatoma 7288C. , 1985, Biochimica et biophysica acta.

[39]  S. Ruggieri,et al.  Lipid composition of SV40-induced transplantable hamster tumor , 1979, Lipids.

[40]  T. Papayannopoulou,et al.  Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. , 1977, The American journal of medicine.

[41]  M. Weber,et al.  Membrane lipid acyl group alterations in cells infected with a temperature-conditional mutant of Rous sarcoma virus. , 1976, Biochimica et Biophysica Acta.

[42]  M. Weber,et al.  Changes in acyl group composition of phospholipids from chicken embryonic fibroblasts after transformation by Rous sarcoma virus. , 1972, Biochemical and biophysical research communications.

[43]  I. Rosenblum,et al.  FATTY ACID ANALYSIS OF TWO EXPERIMENTAL TRANSMISSIBLE GLIAL TUMORS BY GAS-LIQUID CHROMATOGRAPHY. , 1965, Cancer research.

[44]  F. Haven,et al.  The nature of the fatty acids of rats growing Walker carcinoma 256. , 1951, Cancer research.

[45]  Jacques Ferlay,et al.  Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. , 2017, European urology.

[46]  R. A. Igal,et al.  Inhibition of Stearoyl-CoA Desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis. , 2008, International journal of oncology.

[47]  J. Palou,et al.  Multivariate analysis of the prognostic factors of primary superficial bladder cancer. , 2000, The Journal of urology.

[48]  M. Uusitupa,et al.  Fatty acid composition of breast adipose tissue in breast cancer patients and in patients with benign breast disease. , 1995, Nutrition and cancer.

[49]  W. Peel,et al.  The fatty acyl chain composition of human normal and leukaemic lymphocytes and its modulation by specialised hydrogenation. , 1983, Leukemia research.

[50]  S. Weinhouse,et al.  Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. , 1953, Cancer research.